Basal Cell Carcinoma: Skin Signs, Biopsy, Mohs and Treatment
Basal cell carcinoma explained: persistent skin lesions, local tissue damage, biopsy, excision and Mohs, selected creams and medicines, safety and funding.
Cancer
Independent, primary-sourced research on cancer prevention and supplement claims — evidence graded honestly, with industry funding and conflicts disclosed.
Kidney cancer (renal cell carcinoma): diagnosis, kidney-sparing care and urgent signs
Understand adult kidney cancer and RCC, renal imaging and biopsy, partial or total nephrectomy, surveillance, inherited risk, urgent symptoms and source funding.
Acute Myeloid Leukemia (AML): Symptoms, Diagnosis and Care
Acute myeloid leukemia (AML): symptoms, marrow testing, the urgent APL distinction, treatment pathways, infection safety, supplement risks and funding disclosures.
Melanoma: Skin and Nail Symptoms, Biopsy, Staging and Treatment
Melanoma explained: changing skin or nail lesions, biopsy and staging, surgery and selected medicines, treatment risks, sun protection and source funding.
Bladder cancer: blood in urine, NMIBC and MIBC diagnosis and treatment
Understand urothelial bladder cancer, blood in urine, stage versus grade, NMIBC and MIBC care, urinary diversion, urgent symptoms and the funding behind the sources.
Breast cancer: symptoms, diagnosis, stages and treatment decisions
Understand breast cancer types, ER/PR/HER2 tests, staging, treatment options, urgent symptoms and supplement risks, with source funding clearly disclosed.
Acute Lymphoblastic Leukemia (ALL): Symptoms, Diagnosis and Care
Acute lymphoblastic leukemia (ALL): symptoms, B- and T-cell diagnosis, adult treatment pathways, infection warnings, supplement interactions and funding limits.
Acesulfame-K (Ace-K): Independent Evidence on Cancer Risk & Safety
The unreplicated cancer cohort signal — what it means. Independent human-trial evidence, funding traced, evidence graded.
Aspartame: Cancer Evidence, Intake Limits and Safety
Aspartame evidence on cancer, cognition, glucose and PKU, with regulatory intake limits, study limitations and reported funding conflicts.
Cancer Supplements and Food Claims: Evidence and Safety
Key takeaways The strongest ingredient-level evidence is for food, not pills: a dose-response meta-analysis found every 10 g/day increase in dietary fiber was associated with a 10% lower colorectal cancer risk (RR 0.90), and three daily servings of whole grains were linked to a 17% lower risk (RR 0.83). A WHO-commissioned review included 47 trials … Read more